nach oben

Medical Molecular Morphology

Erschienen in:

05.04.2019 | Letter to the editor

Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond

verfasst von: Christine A. Fargeas, Jana Karbanová, Denis Corbeil

Erschienen in: Medical Molecular Morphology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor, …

Sakaue T, Koga H, Iwamoto H, Nakamura T, Ikezono Y, Abe M, Wada F, Masuda A, Tanaka T, Fukahori M, Ushijima T, Mihara Y, Naitou Y, Okabe Y, Kakuma T. Ohta K, Nakamura KI, Torimura T (2019) Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer. Med Mol Morphol. https://doi.org/10.1007/s00795-019-00218-5(epub ahead of print) CrossRefPubMed

Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3):313–323CrossRef

Heiler S, Wang Z, Zöller M (2016) Pancreatic cancer stem cell markers and exosomes—the incentive push. World J Gastroenterol 22(26):5971–6007CrossRef

Lee YJ, Wu CC, Li JW, Ou CC, Hsu SC, Tseng HH, Kao MC, Liu JY (2016) A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Oncotarget 7(48):78499–78515PubMedPubMedCentral

Lardon J, Corbeil D, Huttner WB, Ling Z, Bouwens L (2008) Stem cell marker prominin-1/AC133 is expressed in duct cells of the adult human pancreas. Pancreas 36(1):e1–e6CrossRef

Immervoll H, Hoem D, Sakariassen P, Steffensen OJ, Molven A (2008) Expression of the “stem cell marker” CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 8:48CrossRef

Karbanová J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerová H, Jászai J, Ehrmann J, Kolár Z, Liebers C, Arl S, Subrtová D, Freund D, Mokrý J, Huttner WB. Corbeil D (2008) The stem cell marker CD133 (prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 56(11):977–993CrossRef

Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, Corbeil D (2005) Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 319(1):15–26CrossRef

Marzesco AM, Janich P, Wilsch-Bräuninger M, Dubreuil V, Langenfeld K, Corbeil D, Huttner WB (2005) Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 118(Pt 13):2849–2858CrossRef

10.

Huttner HB, Janich P, Köhrmann M, Jászai J, Siebzehnrubl F, Blümcke I, Suttorp M, Gahr M, Kuhnt D, Nimsky C, Krex D, Schackert G, Löwenbrück K, Reichmann H, Jüttler E. Hacke W, Schellinger PD, Schwab S, Wilsch-Bräuninger M, Marzesco AM, Corbeil D (2008) The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells 26(3):698–705CrossRef

11.

Marzesco AM (2013) Prominin-1-containing membrane vesicles: origins, formation, and utility. Adv Exp Med Biol 777:41–54CrossRef

12.

Bauer N, Wilsch-Bräuninger M, Karbanová J, Fonseca AV, Strauss D, Freund D, Thiele C, Huttner WB, Bornhäuser M, Corbeil D (2011) Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles—a role of the endocytic-exocytic pathway. EMBO Mol Med 3(7):398–409CrossRef

13.

Rappa G, Mercapide J, Anzanello F, Le TT, Johlfs MG, Fiscus RR, Wilsch-Bräuninger M, Corbeil D, Lorico A (2013) Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells. Exp Cell Res 319(6):810–819CrossRef

14.

Chao OS, Chang TC, Di Bella MA, Alessandro R, Anzanello F, Rappa G, Goodman OB, Lorico A (2017) The HDAC6 inhibitor tubacin induces release of CD133(+) extracellular vesicles from cancer cells. J Cell Biochem 118(12):4414–4424CrossRef

15.

Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Théry C (2016) Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA 113(8):E968–E977CrossRef

16.

Bobinger T, May L, Lücking H, Kloska SP, Burkardt P, Spitzer P, Maler JM, Corbeil D, Huttner HB (2017) CD133-positive membrane particles in cerebrospinal fluid of patients with inflammatory and degenerative neurological diseases. Front Cell Neurosci 11:77CrossRef

17.

Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90(12):5013–5021CrossRef

18.

Zhou F, Cui C, Ge Y, Chen H, Li Q, Yang Z, Wu G, Sun S, Chen K, Gu J, Jiang J, Wei Y (2010) Alpha2,3-Sialylation regulates the stability of stem cell marker CD133. J Biochem 148(3):273–280CrossRef

19.

Corbeil D, Röper K, Hellwig A, Tavian M, Miraglia S, Watt SM, Simmons PJ, Peault B, Buck DW, Huttner WB (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275(8):5512–5520CrossRef

20.

Karbanová J, Laco J, Marzesco AM, Janich P, Voborníková M, Mokrý J, Fargeas CA, Huttner WB, Corbeil D (2014) Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form. PLoS One 9(6):e98927CrossRef

21.

Boivin D, Labbé D, Fontaine N, Lamy S, Beaulieu E, Gingras D, Béliveau R (2009) The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemistry 48(18):3998–4007CrossRef

22.

Yang F, Xing Y, Li Y, Chen X, Jiang J, Ai Z, Wei Y (2018) Monoubiquitination of cancer stem cell marker CD133 at lysine 848 regulates Its secretion and promotes cell migration. Mol Cell Biol 38(15):e00024–e00018CrossRef

23.

Corbeil D, Karbanová J, Fargeas CA, Jászai J (2013) Prominin-1 (CD133): molecular and cellular features across species. Adv Exp Med Biol 777:3–24CrossRef

24.

Bidlingmaier S, Zhu X, Liu B (2008) The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med (Berl) 86(9):1025–1032CrossRef

25.

Thamm K, Graupner S, Werner C, Huttner WB, Corbeil D (2016) Monoclonal antibodies 13A4 and AC133 do not recognize the canine ortholog of mouse and human stem cell antigen prominin-1 (CD133). PLoS One 11(10):e0164079CrossRef

26.

Pötgens AJ, Schmitz U, Kaufmann P, Frank HG (2002) Monoclonal antibody CD133-2 (AC141) against hematopoietic stem cell antigen CD133 shows crossreactivity with cytokeratin 18. J Histochem Cytochem 50(8):1131–1134CrossRef

Titel: Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond
verfasst von: Christine A. Fargeas
Jana Karbanová
Denis Corbeil
Publikationsdatum: 05.04.2019
Verlag: Springer Singapore
Erschienen in: Medical Molecular Morphology / Ausgabe 1/2020
Print ISSN: 1860-1480
Elektronische ISSN: 1860-1499
DOI: https://doi.org/10.1007/s00795-019-00221-w

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Springer Medizin

Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond

Excerpt

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Ultrastructure and three-dimensional architecture of the anterior cruciate ligament in the knee joints of young and old monkeys

Three-dimensional architecture of the acetabular labrum in the human hip joint

Stage-dependent differential gene expression profiles of cranial neural crest-like cells derived from mouse-induced pluripotent stem cells

Idiopathic copper toxicosis: is abnormal copper metabolism a primary cause of this disease?

Cavin-1 is linked to lipid droplet formation in human hepatic stellate cells

Expression of fatty-acid-binding protein 5 in intrahepatic and extrahepatic cholangiocarcinoma: the possibility of different energy metabolisms in anatomical location

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien